Genenta Science S.p.a.

Biotechnology • Healthcare • Milan, MI, United States • GNTA (NCM)

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.

39 02 26434681 Via Olgettina No. 58, Milan, MI 20132, Italy

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Genenta Science (GNTA): Assessing Valuation After Expanded Anemocyte Partnership Spurs Industry Optimism - Yahoo Finance

Yahoo Finance • Oct 27

Genenta Science stock plunges after $15 million ADS offering - Investing.com

Investing.com • Oct 27

How much stock this cancer gene therapy CEO owns in his company - Stock Titan

Stock Titan • Dec 19

Genenta Science Stock Skyrockets After Strategic Collaboration Announcement - StocksToTrade

StocksToTrade • Oct 25

Genenta Science Shares Experience Unprecedented 284% Surge Post Anemocyte Collaboration Announcement - timothysykes.com

timothysykes.com • Oct 25

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Genenta Science S.p.A. had layoffs?

No layoff events have been recorded for Genenta Science S.p.A. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Genenta Science S.p.A. have?

Genenta Science S.p.A. has approximately 13 employees.

What industry is Genenta Science S.p.A. in?

Genenta Science S.p.A. operates in the Biotechnology industry, within the Healthcare sector.

Is Genenta Science S.p.A. a publicly traded company?

Yes, Genenta Science S.p.A. is publicly traded under the ticker symbol GNTA on the NCM. The company has a market capitalization of approximately $0.03 billion.

Where is Genenta Science S.p.A. headquartered?

Genenta Science S.p.A. is headquartered in Milan, MI, United States at Via Olgettina No. 58, Milan, MI 20132, Italy.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.